AbbVie, Inc. (ABBV)
257.12
+2.12
(+0.83%)
USD |
NYSE |
Sep 11, 16:00
257.29
+0.17
(+0.07%)
After-Hours: 20:00
AbbVie Price : 257.12 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 253.92 | 259.61 | 253.92 | 257.12 | 4.309M |
| Sep 10, 2026 | 251.23 | 255.31 | 249.74 | 255.00 | 4.398M |
| Sep 09, 2026 | 247.73 | 251.18 | 246.77 | 250.91 | 3.867M |
| Sep 08, 2026 | 251.84 | 254.62 | 248.41 | 248.78 | 5.572M |
| Sep 04, 2026 | 257.96 | 258.91 | 255.58 | 256.46 | 4.730M |
| Sep 03, 2026 | 264.00 | 264.25 | 257.14 | 260.21 | 2.879M |
| Sep 02, 2026 | 262.70 | 262.97 | 257.70 | 261.72 | 4.226M |
| Sep 01, 2026 | 260.99 | 262.26 | 257.79 | 259.99 | 3.867M |
| Aug 31, 2026 | 254.17 | 258.24 | 252.33 | 256.42 | 4.315M |
| Aug 28, 2026 | 258.67 | 259.00 | 255.08 | 255.48 | 3.225M |
| Aug 27, 2026 | 260.81 | 262.50 | 257.25 | 258.15 | 4.765M |
| Aug 26, 2026 | 264.60 | 265.00 | 260.31 | 262.90 | 3.309M |
| Aug 25, 2026 | 264.50 | 266.90 | 263.02 | 265.79 | 3.672M |
| Aug 24, 2026 | 263.99 | 266.04 | 262.07 | 264.52 | 3.884M |
| Aug 21, 2026 | 260.70 | 266.84 | 260.10 | 264.96 | 5.157M |
| Aug 20, 2026 | 265.69 | 265.93 | 260.48 | 261.83 | 5.229M |
| Aug 19, 2026 | 261.51 | 266.96 | 259.55 | 265.97 | 5.536M |
| Aug 18, 2026 | 253.93 | 259.18 | 252.41 | 258.92 | 5.010M |
| Aug 17, 2026 | 249.49 | 251.49 | 248.31 | 250.33 | 4.649M |
| Aug 14, 2026 | 250.60 | 250.61 | 247.68 | 249.46 | 4.195M |
| Aug 13, 2026 | 252.94 | 255.30 | 249.35 | 250.82 | 4.370M |
| Aug 12, 2026 | 245.98 | 250.09 | 245.52 | 248.76 | 3.780M |
| Aug 11, 2026 | 248.14 | 250.76 | 247.18 | 250.09 | 4.485M |
| Aug 10, 2026 | 245.65 | 248.01 | 244.03 | 247.97 | 4.210M |
| Aug 07, 2026 | 243.62 | 246.76 | 241.95 | 246.04 | 4.931M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 217.15 |
| Gilead Sciences, Inc. | 143.72 |
| Regeneron Pharmaceuticals, Inc. | 781.49 |
| Amgen, Inc. | 377.35 |
| REGENXBIO, Inc. | 8.53 |
Price Related Metrics
| PE Ratio | 72.70 |
| PS Ratio | 7.079 |
| PEG Ratio | 1.064 |
| Price to Free Cash Flow | 25.03 |
| Earnings Yield | 1.38% |
| Market Cap | 454.35B |
| PEGY Ratio | 1.024 |
| Operating PE Ratio | 20.71 |
| Normalized PE Ratio | 31.93 |